Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Changzhou Medical Bioengineering is a China-based medical device company focused on the design, development, manufacture, and sale of sterile single-use medical devices rather than therapeutics. Its product portfolio spans anesthesiology, laparoscopic surgery, open surgery, urology, and related procedural categories, including infusion pumps, anesthesia puncture kits, urinary catheterization kits, trocars, skin staplers, and surgical staplers. The company appears to operate commercial-stage manufacturing and export activities, with products sold domestically in China and in overseas markets across Europe, the Middle East, Southeast Asia, and Africa. It reports ISO 9001, ISO 13485, and CE-related certifications and maintains an affiliated sterilization facility supporting ethylene oxide sterilization services. Overall, this is a healthcare device manufacturer serving hospital procedural and surgical markets, not a drug-development biotech company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Changzhou Medical Bioengineering.